OPTINOSE INC (OPTN) Stock Overview
USA - NASDAQ:OPTN - US68404V2097 - Common Stock
OPTN Key Statistics, Chart & Performance
The current stock price of OPTN is 9.6 USD. In the past month the price increased by 4.69%. In the past year, price decreased by -42.34%.
OPTN Latest News, Press Relases and Analysis
OPTN Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 50.78 | 776.19B | ||
| JNJ | JOHNSON & JOHNSON | 18.01 | 450.19B | ||
| AZN | ASTRAZENECA PLC-SPONS ADR | 18.61 | 256.13B | ||
| NVS | NOVARTIS AG-SPONSORED ADR | 13.95 | 238.94B | ||
| NVO | NOVO-NORDISK A/S-SPONS ADR | 13.38 | 231.28B | ||
| MRK | MERCK & CO. INC. | 11.3 | 217.38B | ||
| PFE | PFIZER INC | 7.23 | 139.30B | ||
| SNY | SANOFI-ADR | 11.55 | 124.44B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 6.36 | 87.16B | ||
| GSK | GSK PLC-SPON ADR | 9.75 | 87.89B | ||
| ZTS | ZOETIS INC | 23.38 | 64.44B | ||
| TAK | TAKEDA PHARMACEUTIC-SP ADR | 50.36 | 44.53B |
Related stock screener links
About OPTN
Company Profile
OptiNose, Inc. operates as a pharmaceutical company. The company is headquartered in Yardley, Pennsylvania and currently employs 127 full-time employees. The company went IPO on 2017-10-13. The firm's product, XHANCE (fluticasone propionate) nasal spray, 93 microgram (mcg), is a therapeutic utilizing its Exhalation Delivery System (EDS) that delivers a topically-acting corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps and chronic rhinosinusitis without nasal polyps (also known as chronic sinusitis). XHANCE combines the EDS with a liquid formulation of fluticasone propionate, a well-characterized, second-generation corticosteroid. XHANCE is designed to deliver medication into the high and deep regions of the nasal passages where both nasal polyps and inflamed and swollen membranes can obstruct normal sinus ventilation and drainage. The company has developed both a liquid delivery EDS and a powder delivery EDS utilizing natural functional behaviors of the upper nasal airways intended to offer better drug deposition.
Company Info
OPTINOSE INC
777 Township Line Road, Suite 300
Yardley PENNSYLVANIA 19067 US
CEO: Peter K. Miller
Employees: 128
Phone: 12673643500
OPTINOSE INC / OPTN FAQ
What does OPTN do?
OptiNose, Inc. operates as a pharmaceutical company. The company is headquartered in Yardley, Pennsylvania and currently employs 127 full-time employees. The company went IPO on 2017-10-13. The firm's product, XHANCE (fluticasone propionate) nasal spray, 93 microgram (mcg), is a therapeutic utilizing its Exhalation Delivery System (EDS) that delivers a topically-acting corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps and chronic rhinosinusitis without nasal polyps (also known as chronic sinusitis). XHANCE combines the EDS with a liquid formulation of fluticasone propionate, a well-characterized, second-generation corticosteroid. XHANCE is designed to deliver medication into the high and deep regions of the nasal passages where both nasal polyps and inflamed and swollen membranes can obstruct normal sinus ventilation and drainage. The company has developed both a liquid delivery EDS and a powder delivery EDS utilizing natural functional behaviors of the upper nasal airways intended to offer better drug deposition.
Can you provide the latest stock price for OPTINOSE INC?
The current stock price of OPTN is 9.6 USD. The price decreased by -1.13% in the last trading session.
Does OPTINOSE INC pay dividends?
OPTN does not pay a dividend.
How is the ChartMill rating for OPTINOSE INC?
OPTN has a ChartMill Technical rating of 9 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
Where is OPTINOSE INC (OPTN) stock traded?
OPTN stock is listed on the Nasdaq exchange.
What is the GICS sector and industry of OPTN stock?
OPTINOSE INC (OPTN) operates in the Health Care sector and the Pharmaceuticals industry.
What is the market capitalization of OPTN stock?
OPTINOSE INC (OPTN) has a market capitalization of 97.25M USD. This makes OPTN a Micro Cap stock.
OPTN Technical Analysis
ChartMill assigns a technical rating of 9 / 10 to OPTN. When comparing the yearly performance of all stocks, OPTN is one of the better performing stocks in the market, outperforming 82.3% of all stocks.
OPTN Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to OPTN. Both the profitability and financial health of OPTN have multiple concerns.
OPTN Financial Highlights
Over the last trailing twelve months OPTN reported a non-GAAP Earnings per Share(EPS) of -2.73. The EPS decreased by -40% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -27.65% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
OPTN Forecast & Estimates
10 analysts have analysed OPTN and the average price target is 9.18 USD. This implies a price decrease of -4.37% is expected in the next year compared to the current price of 9.6.
For the next year, analysts expect an EPS growth of 1.39% and a revenue growth 27.03% for OPTN